Nano-X Imaging (NNOX) Stock Price, News & Analysis

Company Overview

Nano-X Imaging Ltd is a medical technology company focused on the development and commercialization of digital X-ray imaging systems. Founded in 2014 and headquartered in Israel, the company applies proprietary carbon nanotube and cold cathode array technology to create compact, cost-effective imaging devices designed to improve global access to diagnostic screening. Nano-X Imaging went public in 2021 following a merger with a special purpose acquisition company, and its shares trade on the NASDAQ under the symbol NNOX.

The company’s flagship product, the Nanox.ARC, features a novel micro-focus X-ray source that enables high-resolution imaging at reduced hardware complexity. Unlike traditional X-ray tubes, Nanox.ARC’s cold cathode arrays can be switched on and off rapidly, supporting a scanning workflow that captures multiple projections in a single examination. Nano-X complements its hardware offering with a cloud-based platform for image storage, processing and delivery, allowing healthcare providers to manage and review studies remotely.

Nano-X Imaging pursues an “Imaging as a Service” model that bundles equipment deployment with ongoing maintenance and service agreements. This subscription-style approach aims to lower the upfront capital barrier for hospitals and clinics, particularly in regions with limited radiology infrastructure. To date, the company has secured regulatory clearances and strategic partnerships in multiple markets, including the United States, Japan, Europe and the Middle East, with pilot installations underway to demonstrate clinical workflows and throughput.

Under the leadership of founder and CEO Ran Poliakine, Nano-X Imaging continues to expand its manufacturing capabilities and strengthen distribution channels. The executive team combines expertise in medical devices, regulatory affairs and cloud software development, with the goal of scaling large-scale screening programs and addressing unmet needs in preventive care. As Nano-X brings its novel imaging platform to market, it seeks to reshape the economics of radiology and enhance access to diagnostic services worldwide.

Key Stats

• Today's Range: $5.00 to $5.14
• 50-Day Range: $4.93 to $5.71
• 52-Week Range: $3.75 to $11.00
• Volume: 1.00 million shs
• Average Volume: 1.73 million shs
• Market Capitalization: $292.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.50
• Consensus Rating: Buy

Nano-X Imaging Stock Analysis - MarketRank™

Nano-X Imaging scored higher than 40% of companies evaluated by MarketBeat, and ranked 214th out of 320 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Nano-X Imaging has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Nano-X Imaging has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Nano-X Imaging are expected to grow in the coming year, from ($0.92) to ($0.62) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Nano-X Imaging is -5.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nano-X Imaging is -5.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nano-X Imaging has a P/B Ratio of 1.55. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.70% of the float of Nano-X Imaging has been sold short.

Short Interest Ratio / Days to Cover

Nano-X Imaging has a short interest ratio ("days to cover") of 6.6.

Change versus previous month

Short interest in Nano-X Imaging has recently decreased by 0.59%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nano-X Imaging does not currently pay a dividend.

Dividend Growth

Nano-X Imaging does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

12.70% of the float of Nano-X Imaging has been sold short.

Short Interest Ratio / Days to Cover

Nano-X Imaging has a short interest ratio ("days to cover") of 6.6.

Change versus previous month

Short interest in Nano-X Imaging has recently decreased by 0.59%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: N/A

News Sentiment

Nano-X Imaging has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Nano-X Imaging this week, compared to 2 articles on an average week.

Search Interest

Only 10 people have searched for NNOX on MarketBeat in the last 30 days. This is a decrease of -23% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Nano-X Imaging to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nano-X Imaging insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 21.49% of the stock of Nano-X Imaging is held by institutions.

NNOX Stock Analysis - Frequently Asked Questions

How have NNOX shares performed this year?

Nano-X Imaging's stock was trading at $7.20 at the beginning of 2025. Since then, NNOX stock has decreased by 29.7% and is now trading at $5.06.

How were Nano-X Imaging's earnings last quarter?

Nano-X Imaging Ltd. (NASDAQ:NNOX) released its earnings results on Thursday, May, 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.02. The company had revenue of $3 million for the quarter, compared to analyst estimates of $3.98 million. Nano-X Imaging had a negative trailing twelve-month return on equity of 30.92% and a negative net margin of 472.19%.
Read the conference call transcript.

When did Nano-X Imaging IPO?

Nano-X Imaging (NNOX) raised $100 million in an initial public offering on Friday, August 21st 2020. The company issued 5,900,000 shares at a price of $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets served as the underwriters for the IPO and National Securities Corp. was co-manager.

Who are Nano-X Imaging's major shareholders?

Top institutional shareholders of Nano-X Imaging include Wesbanco Bank Inc. (0.10%) and Westmount Partners LLC (0.04%).

How do I buy shares of Nano-X Imaging?

Shares of NNOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nano-X Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nano-X Imaging investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Bakkt (BKKT) and Virgin Galactic (SPCE).

Company Calendar

• Last Earnings: 5/22/2025
• Today: 7/13/2025
• Next Earnings (Estimated): 8/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Technology Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NNOX
• CIK: 1795251
• Web: www.nanox.vision
• Phone: 972-02-536-0360
• Fax: 972-02-544-5214
• Employees: 190
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Nano-X Imaging: $9.50
• High Price Target: $10.00
• Low Price Target: $9.00
• Potential Upside/Downside: +87.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.90)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$53.52 million
• Net Margins: -472.19%
• Pretax Margin: -475.22%
• Return on Equity: -30.92%
• Return on Assets: -27.73%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.30
• Quick Ratio: 5.16

Sales & Book Value

• Annual Sales: $11.28 million
• Price / Sales: 25.92
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.27 per share
• Price / Book: 1.55

Miscellaneous

• Outstanding Shares: 57,780,000
• Free Float: N/A
• Market Cap: $292.37 million
• Optionable: Optionable
• Beta: 1.96